Search
for
Sort by
Research 601–630 of 1000+
- Advancements in Drug Repurposing: Examples in Psychiatric Medications
- Use of the drug Wolvit® (biotin 5 mg) in treatment of defuse telogenous alopecia
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Potential of Aloe vera in Dermato-cosmetology: An Integrative Appraisal of Unani Therapeutics and Contemporary Biomedical Evidence
- Prospects for the use of physiotherapy methods in the treatment of telogen alopecia
- Hair Follicles: Strategic Targets for Promoting Hair Growth
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- Light-Emitting Hair Follicles: Studying Skin Regeneration With In Vivo Imaging
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- Hollow polydopamine nanoparticles loading with peptide RL-QN15: a new pro-regenerative therapeutic agent for skin wounds
- Lipid-Based Drug Delivery Systems in Regenerative Medicine
- Application of Scaffold-Based Drug Delivery in Oral Cancer Treatment: A Novel Approach
- Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles
- Composite Hydrogel Dressing with Drug-Release Capability and Enhanced Mechanical Performance
- Combining rapid degrading microneedles with Slow-Released drug delivery system for the treatment of alopecia areata
- Multiple crosslinked, self-healing, and shape-adaptable hydrogel laden with pain-relieving chitosan@borneol nanoparticles for infected burn wound healing
- Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- FGF Family: From Drug Development to Clinical Application
- PROTACs: A novel strategy for cancer drug discovery and development
- Using the zebrafish lateral line to uncover novel mechanisms of action and prevention in drug-induced hair cell death
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Imatinib-induced classical lichen planopilaris in blaschko-linear distribution leading to cicatricial alopecia
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Evolving CRBN ligands enhance the drug-like properties of protein degraders